OS Therapies (OSTX) Achieves Key Milestone As Patient Enrolment Concludes
Fahim Awan
October 3, 2024
Shares of OS Therapies Incorporated (NYSE: OSTX) experienced a significant rise following the completion of patient enrolment in its AOST-2121 clinical trial. As of the